|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018418,
umls-concept:C0024902,
umls-concept:C0030705,
umls-concept:C0035820,
umls-concept:C0039286,
umls-concept:C0194810,
umls-concept:C0205263,
umls-concept:C0285590,
umls-concept:C0376358,
umls-concept:C0677850,
umls-concept:C1522449
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-11-10
|
|
pubmed:abstractText |
We investigated the role of tamoxifen and radiotherapy (RT) for the prevention and treatment of gynecomastia and breast pain during adjuvant bicalutamide monotherapy after radical prostatectomy (RP) in patients with prostate cancer. Also, we evaluated their effects on patient hormonal status, quality of life (QOL), sexual function and prostate specific antigen relapse-free survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Androgens,
http://linkedlifedata.com/resource/pubmed/chemical/Anilides,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor Modulators,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/bicalutamide
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
174
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2197-203
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16280763-Aged,
pubmed-meshheading:16280763-Androgen Antagonists,
pubmed-meshheading:16280763-Androgens,
pubmed-meshheading:16280763-Anilides,
pubmed-meshheading:16280763-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16280763-Chemotherapy, Adjuvant,
pubmed-meshheading:16280763-Disease-Free Survival,
pubmed-meshheading:16280763-Estrogen Receptor Modulators,
pubmed-meshheading:16280763-Follow-Up Studies,
pubmed-meshheading:16280763-Gynecomastia,
pubmed-meshheading:16280763-Humans,
pubmed-meshheading:16280763-Male,
pubmed-meshheading:16280763-Middle Aged,
pubmed-meshheading:16280763-Nitriles,
pubmed-meshheading:16280763-Pain,
pubmed-meshheading:16280763-Penile Erection,
pubmed-meshheading:16280763-Prospective Studies,
pubmed-meshheading:16280763-Prostate-Specific Antigen,
pubmed-meshheading:16280763-Prostatectomy,
pubmed-meshheading:16280763-Prostatic Neoplasms,
pubmed-meshheading:16280763-Quality of Life,
pubmed-meshheading:16280763-Radiotherapy, Adjuvant,
pubmed-meshheading:16280763-Severity of Illness Index,
pubmed-meshheading:16280763-Tamoxifen,
pubmed-meshheading:16280763-Testosterone,
pubmed-meshheading:16280763-Time Factors,
pubmed-meshheading:16280763-Tosyl Compounds,
pubmed-meshheading:16280763-Treatment Outcome,
pubmed-meshheading:16280763-Tumor Markers, Biological
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
|
|
pubmed:affiliation |
Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università degli Studi Federico II, Vico Santo Spirito 54, 80132 Naples, Italy. giuseppedilorenzoncol@hotnail.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
